Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Milestone Pharmaceuticals stock

Own Milestone Pharmaceuticals stock in just a few minutes.

Milestone Pharmaceuticals Inc is a biotechnology business based in the US. Milestone Pharmaceuticals shares (MIST) are listed on the NASDAQ and all prices are listed in US Dollars. Milestone Pharmaceuticals employs 28 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Milestone Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MIST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Milestone Pharmaceuticals share price

Use our graph to track the performance of MIST stocks over time.

Milestone Pharmaceuticals shares at a glance

Information last updated 2021-03-10.
52-week range$1.71 - $19.60
50-day moving average $7.67
200-day moving average $7.20
Wall St. target price$14.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-10.84

Buy Milestone Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Milestone Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Milestone Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -30.34%
Return on equity TTM -50.71%
Profit margin 0%
Book value $4.13
Market capitalisation $217.7 million

TTM: trailing 12 months

Shorting Milestone Pharmaceuticals shares

There are currently 252,880 Milestone Pharmaceuticals shares held short by investors – that's known as Milestone Pharmaceuticals's "short interest". This figure is 7% up from 236,294 last month.

There are a few different ways that this level of interest in shorting Milestone Pharmaceuticals shares can be evaluated.

Milestone Pharmaceuticals's "short interest ratio" (SIR)

Milestone Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Milestone Pharmaceuticals shares currently shorted divided by the average quantity of Milestone Pharmaceuticals shares traded daily (recently around 141273.74301676). Milestone Pharmaceuticals's SIR currently stands at 1.79. In other words for every 100,000 Milestone Pharmaceuticals shares traded daily on the market, roughly 1790 shares are currently held short.

However Milestone Pharmaceuticals's short interest can also be evaluated against the total number of Milestone Pharmaceuticals shares, or, against the total number of tradable Milestone Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Milestone Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Milestone Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0114% of the tradable shares (for every 100,000 tradable Milestone Pharmaceuticals shares, roughly 11 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Milestone Pharmaceuticals.

Find out more about how you can short Milestone Pharmaceuticals stock.

Milestone Pharmaceuticals share dividends

We're not expecting Milestone Pharmaceuticals to pay a dividend over the next 12 months.

Milestone Pharmaceuticals overview

Milestone Pharmaceuticals Inc. , a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site